<!DOCTYPE html>

<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>Trimethyltrienolone - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Trimethyltrienolone","wgTitle":"Trimethyltrienolone","wgCurRevisionId":890306360,"wgRevisionId":890306360,"wgArticleId":51309714,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 French-language sources (fr)","Articles without EBI source","Chemical pages without DrugBank identifier","Articles without KEGG source","Articles without UNII source","Drugs with no legal status","Articles containing unverified chemical infoboxes","Drugs not assigned an ATC code","Abandoned drugs","Alcohols","Estranes","Hepatotoxins","Ketones","Steroidal antiandrogens"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Trimethyltrienolone","wgRelevantArticleId":51309714,"wgRequestId":"XL7ofQpAICoAAFhnhikAAAAT","wgCSPNonce":false,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsReferencePreviews":false,"wgPopupsConflictsWithNavPopupGadget":false,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en","usePageImages":true,"usePageDescriptions":true},"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgWMESchemaEditAttemptStepOversample":false,"wgPoweredByHHVM":true,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgWikibaseItemId":"Q28209097","wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true});mw.loader.state({"ext.gadget.charinsert-styles":"ready","ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready","user":"ready","user.options":"ready","user.tokens":"loading","ext.cite.styles":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","jquery.makeCollapsible.styles":"ready","mediawiki.toc.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","ext.3d.styles":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready"});mw.loader.implement("user.tokens@0tffind",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.startup","mediawiki.page.ready","jquery.tablesorter","jquery.makeCollapsible","mediawiki.toc","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.compactlinks","ext.uls.interface","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"];mw.loader.load(RLPAGEMODULES);});</script>
<link href="/w/load.php?lang=en&amp;modules=ext.3d.styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.toc.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?lang=en&amp;modules=ext.gadget.charinsert-styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<link href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.34.0-wmf.1" name="generator"/>
<meta content="origin" name="referrer"/>
<meta content="origin-when-crossorigin" name="referrer"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<meta content="https://upload.wikimedia.org/wikipedia/commons/thumb/9/9d/R-2956.svg/1200px-R-2956.svg.png" property="og:image"/>
<link href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Trimethyltrienolone" rel="alternate"/>
<link href="/w/index.php?title=Trimethyltrienolone&amp;action=edit" rel="alternate" title="Edit this page" type="application/x-wiki"/>
<link href="/w/index.php?title=Trimethyltrienolone&amp;action=edit" rel="edit" title="Edit this page"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="license"/>
<link href="https://en.wikipedia.org/wiki/Trimethyltrienolone" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
<!--[if lt IE 9]><script src="/w/load.php?lang=qqx&amp;modules=html5shiv&amp;only=scripts&amp;skin=fallback&amp;sync=1"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Trimethyltrienolone rootpage-Trimethyltrienolone skin-vector action-view">
<div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">

<div class="mw-body-content" id="siteNotice"><!-- CentralNotice --></div>
<div class="mw-indicators mw-body-content">
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">Trimethyltrienolone</h1>
<div class="mw-body-content" id="bodyContent">
<div class="noprint" id="siteSub">From Wikipedia, the free encyclopedia</div>
<div id="contentSub"></div>
<div id="jump-to-nav"></div>
Jump to navigation
Jump to search
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><div class="mw-parser-output"><table class="infobox" style="width:22em;border-spacing:2px;"><caption><span title="International nonproprietary name (INN): Trimethyltrienolone">Trimethyltrienolone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><img alt="R-2956.svg" data-file-height="312" data-file-width="512" decoding="async" height="137" src="https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https://upload.wikimedia.org/wikipedia/commons/thumb/9/9d/R-2956.svg/225px-R-2956.svg.png" srcset width="225"/></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Synonyms</th><td>TMT; R-2956; RU-2956; 2Î±,2Î²,17Î±-Trimethyltrienolone; 2Î±,2Î²,17Î±-Trimethyltrenbolone; 2Î±,2Î²-Dimethylmetribolone; Î´-2Î±,2Î²,17Î±-trimethyl-19-nortestosterone; 2Î±,2Î²,17Î±-Trimethylestra-4,9,11-trien-17Î²-ol-3-one; 17Î²-Hydroxy-2Î±,2Î²,17Î±-trimethylestra-4,9,11-trien-3-one</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Steroidal antiandrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>None</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(8<i>R</i>,13<i>S</i>,14<i>S</i>,17<i>R</i>)-17-hydroxy-2,2,13,17-tetramethyl-6,7,8,14,15,16-hexahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthren-3-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span title="www.commonchemistry.org">23983-19-9</span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal">CID</abbr></span></th><td><div class="plainlist"><ul><li><span title="pubchem.ncbi.nlm.nih.gov">170652</span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span title="www.chemspider.com">149197</span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span title="Carbon">C</span><sub>21</sub><span title="Hydrogen">H</span><sub>28</sub><span title="Oxygen">O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>312.453 g/molÂ gÂ·mol</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span title="chemapps.stolaf.edu (3D interactive model)">Interactive image</span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC1(CC2=C3C=CC4(C(C3CCC2=CC1=O)CCC4(C)O)C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C21H28O2/c1-19(2)12-16-13(11-18(19)22)5-6-15-14(16)7-9-20(3)17(15)8-10-21(20,4)23/h7,9,11,15,17,23H,5-6,8,10,12H2,1-4H3/t15-,17-,20-,21+/m0/s1</div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:VFKZTCQVCJGPGF-STRKUORWSA-N</div></li></ul>
</div></td></tr></tbody></table>
<p><b>Trimethyltrienolone</b> (<b>TMT</b>), also known by its developmental code name <b>R-2956</b> or <b>RU-2956</b>, is an antiandrogen medication which was never introduced for medical use but has been used in scientific research.
<span style="border: 3px solid blue; color:blue;font-weight: bold">1</span></p>
<div class="toc" id="toc"><input class="toctogglecheckbox" id="toctogglecheckbox" role="button" style="display:none" type="checkbox"/><div class="toctitle" dir="ltr" lang="en"><h2>Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><span class="tocnumber">1</span> <span class="toctext">Side effects</span></li>
<li class="toclevel-1 tocsection-2"><span class="tocnumber">2</span> <span class="toctext">Pharmacology</span>
<ul>
<li class="toclevel-2 tocsection-3"><span class="tocnumber">2.1</span> <span class="toctext">Pharmacodynamics</span></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><span class="tocnumber">3</span> <span class="toctext">Chemistry</span></li>
<li class="toclevel-1 tocsection-5"><span class="tocnumber">4</span> <span class="toctext">History</span></li>
<li class="toclevel-1 tocsection-6"><span class="tocnumber">5</span> <span class="toctext">References</span></li>
</ul>
</div>
<h2><span class="mw-headline" id="Side_effects">Side effects</span></h2>
<p>Due to its close relation to metribolone (methyltrienolone), it is thought that TMT may produce hepatotoxicity.
<span style="border: 3px solid blue; color:blue;font-weight: bold">2</span></p>
<h2><span class="mw-headline" id="Pharmacology">Pharmacology</span></h2>
<h3><span class="mw-headline" id="Pharmacodynamics">Pharmacodynamics</span></h3>
<p>TMT is a selective and highly potent competitive antagonist of the androgen receptor (AR) with very low intrinsic/partial androgenic activity and no estrogenic, antiestrogenic, progestogenic, or antimineralocorticoid activity. The drug is a derivative of the extremely potent androgen/anabolic steroid metribolone (R-1881; 17Î±-methyltrenbolone), and has been reported to possess only about 4-fold lower affinity for the AR in comparison. In accordance, it has relatively high affinity for the AR among steroidal antiandrogens, and almost completely inhibits dihydrotestosterone (DHT) binding to the AR <i>in vitro</i> at a mere 10-fold molar excess. The AR weak partial agonistic activity of TMT is comparable to that of cyproterone acetate.
<span style="border: 3px solid blue; color:blue;font-weight: bold">3</span></p>
<table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap">Relative affinities (%) of TMT and related steroids
</caption>
<tbody><tr>
<th>Compound</th>
<th>PR</abbr></th>
<th>AR</abbr></th>
<th>ER</abbr></th>
<th>GR</abbr></th>
<th>MR</abbr>
</th></tr>
<tr>
<td>Testosterone</td>
<td>1â€“3, 1â€“5</td>
<td>100</td>
<td>&lt;1</td>
<td>&lt;1, 1â€“5</td>
<td>&lt;1
</td></tr>
<tr>
<td>5Î±-Dihydrotestosterone</td>
<td>&lt;1, 1â€“3</td>
<td>100â€“125</td>
<td>&lt;1</td>
<td>&lt;1</td>
<td>&lt;1
</td></tr>
<tr>
<td>Metribolone (RU-1881)</td>
<td>200â€“300, 250â€“600</td>
<td>200â€“300, 250â€“600</td>
<td>&lt;1</td>
<td>25â€“50</td>
<td>15â€“25
</td></tr>
<tr>
<td>Trimethyltrienolone (RU-2956)</td>
<td>â‰¤1</td>
<td>14</td>
<td>&lt;1</td>
<td>&lt;1</td>
<td>&lt;1
</td></tr>
<tr class="sortbottom">
<td colspan="6" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are percentages (%). Reference ligands (100%) were progesterone for the PR</abbr>, testosterone for the AR</abbr>, E2</abbr> for the ER</abbr>, DEXA</abbr> for the GR</abbr>, and aldosterone for the MR</abbr>. <b>Sources:</b> 
</td></tr></tbody></table>
<p class="mw-empty-elt"><span style="border: 3px solid blue; color:blue;font-weight: bold">4</span></p><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view">v</abbr></li><li class="nv-talk">t</abbr></li><li class="nv-edit">e</abbr></li></ul></div> Relative affinities (%) of antiandrogens at steroid-hormone receptors
<p class="mw-empty-elt"><span style="border: 3px solid blue; color:blue;font-weight: bold">5</span></p></caption>
<tbody><tr>
<th>Antiandrogen</th>
<th>AR</abbr></th>
<th>PR</abbr></th>
<th>ER</abbr></th>
<th>GR</abbr></th>
<th>MR</abbr>
</th></tr>
<tr>
<td>Cyproterone acetate</td>
<td>8â€“10</td>
<td>60</td>
<td>&lt;0.1</td>
<td>5</td>
<td>1
</td></tr>
<tr>
<td>Chlormadinone acetate</td>
<td>5</td>
<td>175</td>
<td>&lt;0.1</td>
<td>38</td>
<td>1
</td></tr>
<tr>
<td>Megestrol acetate</td>
<td>5</td>
<td>152</td>
<td>&lt;0.1</td>
<td>50</td>
<td>3
</td></tr>
<tr>
<td>Spironolactone</td>
<td>7</td>
<td>0.4</td>
<td>&lt;0.1</td>
<td>2</td>
<td>182
</td></tr>
<tr>
<td>Trimethyltrienolone</td>
<td>3.6</td>
<td>&lt;1</td>
<td>&lt;1</td>
<td>&lt;1</td>
<td>&lt;1
</td></tr>
<tr>
<td>Inocoterone</td>
<td>0.8</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr>
<td>Inocoterone acetate</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr>
<td>Flutamide</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr>
<td>Hydroxyflutamide</td>
<td>0.5â€“0.8</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr>
<td>Nilutamide</td>
<td>0.5â€“0.8</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr>
<td>Bicalutamide</td>
<td>1.8</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1</td>
<td>&lt;0.1
</td></tr>
<tr class="sortbottom">
<td colspan="6" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1): Reference ligands (100%) were testosterone for the AR</abbr>, progesterone for the PR</abbr>, estradiol for the ER</abbr>, dexamethasone for the GR</abbr>, and aldosterone for the MR</abbr>. (2): Tissues were rat prostate (AR), rabbit uterus (PR), mouse uterus (ER), rat thymus (GR), and rat kidney (MR). (3): Incubation times (0Â°C) were 24 hours (AR, ), 2 hours (PR, ER), 4 hours (GR), and 1 hour (MR). (4): Assay methods were different for bicalutamide for receptors besides the AR. <b>Sources:</b> See template.
</td></tr></tbody></table>
<p class="mw-empty-elt"><span style="border: 3px solid blue; color:blue;font-weight: bold">6</span></p><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view">v</abbr></li><li class="nv-talk">t</abbr></li><li class="nv-edit">e</abbr></li></ul></div> Affinities of selected ligands at the androgen receptor
<p class="mw-empty-elt"><span style="border: 3px solid blue; color:blue;font-weight: bold">7</span></p></caption>
<tbody><tr>
<th>Compound</th>
<th>AR</abbr> RBA</abbr> (%)</th>
<th>AR</abbr> K<sub>i</sub> (nM)
</th></tr>
<tr>
<td>Metribolone</td>
<td>100</td>
<td>1.18
</td></tr>
<tr>
<td>Dihydrotestosterone</td>
<td>136</td>
<td>0.87
</td></tr>
<tr>
<td>Testosterone</td>
<td>117</td>
<td>1.01
</td></tr>
<tr>
<td>Spironolactone</td>
<td>67.0</td>
<td>1.76
</td></tr>
<tr>
<td>Trimethyltrienolone</td>
<td>14.8</td>
<td>8.0
</td></tr>
<tr>
<td>Megestrol acetate</td>
<td>13.6</td>
<td>8.7
</td></tr>
<tr>
<td>Cyproterone acetate</td>
<td>12.5</td>
<td>9.5
</td></tr>
<tr>
<td>Progesterone</td>
<td>6.6</td>
<td>18
</td></tr>
<tr>
<td>Estradiol</td>
<td>4.9</td>
<td>24
</td></tr>
<tr>
<td>Androstenedione</td>
<td>2.0</td>
<td>58
</td></tr>
<tr>
<td>Canrenone</td>
<td>0.84</td>
<td>140
</td></tr>
<tr>
<td>Flutamide</td>
<td>0.079</td>
<td>1200
</td></tr>
<tr>
<td>Cimetidine</td>
<td>0.00084</td>
<td>140,000
</td></tr>
<tr class="sortbottom">
<td colspan="3" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Human skin fibroblasts used for assays. (2) Situation <i>in vivo</i> is different for flutamide and spironolactone due biotransformation. (3) Conflicting findings for spironolactone. <b>Sources:</b> See template.
</td></tr></tbody></table>
<h2><span class="mw-headline" id="Chemistry">Chemistry</span></h2>
<div class="hatnote navigation-not-searchable" role="note">See also: Steroidal antiandrogen and List of steroidal antiandrogens</div>
<p>TMT, also known as 2Î±,2Î²,17Î±-trimethyltrienolone or as Î´-2Î±,2Î²,17Î±-trimethyl-19-nortestosterone, as well as 2Î±,2Î²,17Î±-trimethylestra-4,9,11-trien-17Î²-ol-3-one, is a synthetic estrane steroid and a derivative of testosterone and 19-nortestosterone. It is the 2Î±,2Î²,17Î±-trimethyl derivative of trenbolone (trienolone) and the 2Î±,2Î²-dimethyl derivative of metribolone (methyltrienolone), both of which are synthetic androgens/anabolic steroids.
<span style="border: 3px solid blue; color:blue;font-weight: bold">8</span></p>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>TMT was developed by Roussel Uclaf in France and was first known as early as 1969. It was one of the earliest antiandrogens to be discovered and developed, along with others such as benorterone, BOMT, cyproterone, and cyproterone acetate. The drug was under investigation by Roussel Uclaf for potential medical use, but was abandoned in favor of nonsteroidal antiandrogens like flutamide and nilutamide due to their comparative advantage of a complete lack of androgenicity. Roussel Uclaf subsequently developed and introduced nilutamide for medical use.
<span style="border: 3px solid blue; color:blue;font-weight: bold">9</span></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-RaynaudBonne1984-1"><span class="mw-cite-backlink">^  </span> <span class="reference-text"><cite class="citation journal">Raynaud, J. P.; Bonne, C.; Moguilewsky, M.; Lefebvre, F. A.; BÃ©langer, A.; Labrie, F. (1984). "The pure antiandrogen ru 23908 (anandronÂ®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review". <i>The Prostate</i>. <b>5</b> (3): 299â€“311. doi:10.1002/pros.2990050307. ISSNÂ 0270-4137. <q>[...] flutamide but we soon abandoned the development of steroid derivatives such as RU 2956 because of inherent androgenicity [17], and focused on the nonsteroidal antiandrogens.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Prostate&amp;rft.atitle=The+pure+antiandrogen+ru+23908+%28anandron%C2%AE%29%2C+a+candidate+of+choice+for+the+combined+antihormonal+treatment+of+prostatic+cancer%3A+A+review&amp;rft.volume=5&amp;rft.issue=3&amp;rft.pages=299-311&amp;rft.date=1984&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.2990050307&amp;rft.issn=0270-4137&amp;rft.aulast=Raynaud&amp;rft.aufirst=J.+P.&amp;rft.au=Bonne%2C+C.&amp;rft.au=Moguilewsky%2C+M.&amp;rft.au=Lefebvre%2C+F.+A.&amp;rft.au=B%C3%A9langer%2C+A.&amp;rft.au=Labrie%2C+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><style data-mw-deduplicate="TemplateStyles:r886058088">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-NegwerScharnow2001-2"><span class="mw-cite-backlink">^  </span> <span class="reference-text"><cite class="citation book">Martin Negwer; Hans-Georg Scharnow (2001). <i>Organic-chemical drugs and their synonyms: (an international survey)</i>. Wiley-VCH. p.Â 2158. ISBNÂ <bdi>978-3-527-30247-5</bdi>. <q>10635 (8596) C21H28O2 23983-19-9 17Î²-Hydroxy-2,2,17-trimethylestra-4,9,11-trien-3-oneÂ : (17Î²)-17-Hydroxy-2,2,17-trimethylestra-4,9,11-trien-3-one (â€¢) S R 2956 U Anti-androgen</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Organic-chemical+drugs+and+their+synonyms%3A+%28an+international+survey%29&amp;rft.pages=2158&amp;rft.pub=Wiley-VCH&amp;rft.date=2001&amp;rft.isbn=978-3-527-30247-5&amp;rft.au=Martin+Negwer&amp;rft.au=Hans-Georg+Scharnow&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DzmpqAAAAMAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-HughesHasan2013-3"><span class="mw-cite-backlink">^  </span> <span class="reference-text"><cite class="citation book">Hughes A, Hasan SH, Oertel GW (27 November 2013).  Voss HE, Bahner F, Neumann F, Steinbeck H, GrÃ¤f KJ, Brotherton J, Horn HJ, Wagner RK (eds.). <i>Androgens II and Antiandrogens / Androgene II und Antiandrogene</i>. Springer Science &amp; Business Media. pp.Â 1â€“. ISBNÂ <bdi>978-3-642-80859-3</bdi>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Androgens+II+and+Antiandrogens+%2F+Androgene+II+und+Antiandrogene&amp;rft.pages=1-&amp;rft.pub=Springer+Science+%26+Business+Media&amp;rft.date=2013-11-27&amp;rft.isbn=978-3-642-80859-3&amp;rft.aulast=Hughes&amp;rft.aufirst=A&amp;rft.au=Hasan%2C+SH&amp;rft.au=Oertel%2C+GW&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7JPsCAAAQBAJ%26pg%3DPA1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid3543501-4"><span class="mw-cite-backlink">^  </span> <span class="reference-text"><cite class="citation journal">Raynaud JP, Ojasoo T (November 1986). "The design and use of sex-steroid antagonists". <i>J. Steroid Biochem</i>. <b>25</b> (5B): 811â€“33. doi:10.1016/0022-4731(86)90313-4. PMIDÂ 3543501.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Steroid+Biochem.&amp;rft.atitle=The+design+and+use+of+sex-steroid+antagonists&amp;rft.volume=25&amp;rft.issue=5B&amp;rft.pages=811-33&amp;rft.date=1986-11&amp;rft_id=info%3Adoi%2F10.1016%2F0022-4731%2886%2990313-4&amp;rft_id=info%3Apmid%2F3543501&amp;rft.aulast=Raynaud&amp;rft.aufirst=JP&amp;rft.au=Ojasoo%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Azadian-BoulangerBonne1974-5"><span class="mw-cite-backlink">^   </span> <span class="reference-text"><cite class="citation journal">Azadian-Boulanger G, Bonne C, Secchi J, Raynaud JP (1974). "[17beta-hydroxy-2,2,17-trimethyl-estra-4, 9,11-trien-3-one). 1. Profil endocrinien. (Antiandrogenic activity of R2956 (17beta-hydroxy-2,2,17-trimethyl-estra-4,9,11-trien-3-one). 1. Endocrine profile)] Activite anti-androgene du R 2956". <i>Journal de Pharmacologie</i> (in French). <b>5</b> (4): 509â€“520<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2016</span>. <q>R 2956 (17beta-hydroxy-2,2,17-trimethyl-estra-4,9,11-trien-3-one) was tested for antiandrogenic activity in rats (Dorfman test); in dogs; for androgenic activity in female rats (Hershberger); in male rats; for progestagenic activity in rabbits (Clauberg); for uterotrophic activity in mice (Rubin); and for antiestrogenic activity in mice (Dorfman). R 2956 significantly antagonized the hypertrophic effect of .05 mg testosterone propionate on rat seminal vesicles and ventral prostate in proportion to dose from .4-5 mg/day orally. In dogs R 2956 lowered prostate epithelial hyperplasia induced by androstanolone. R 2956 had no androgenic, estrogenic, progestational, or antiestrogenic activities and inhibited development of corpora lutea to an extent comparable with that of norethindrone.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+de+Pharmacologie&amp;rft.atitle=%5B17beta-hydroxy-2%2C2%2C17-trimethyl-estra-4%2C+9%2C11-trien-3-one%29.+1.+Profil+endocrinien.+%28Antiandrogenic+activity+of+R2956+%2817beta-hydroxy-2%2C2%2C17-trimethyl-estra-4%2C9%2C11-trien-3-one%29.+1.+Endocrine+profile%29%5D+Activite+anti-androgene+du+R+2956&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=509-520&amp;rft.date=1974&amp;rft.aulast=Azadian-Boulanger&amp;rft.aufirst=G&amp;rft.au=Bonne%2C+C&amp;rft.au=Secchi%2C+J&amp;rft.au=Raynaud%2C+JP&amp;rft_id=http%3A%2F%2Fwww.popline.org%2Fnode%2F494155&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-JamesPasqualini2013-6"><span class="mw-cite-backlink">^   </span> <span class="reference-text"><cite class="citation book">V. H. T. James; J. R. Pasqualini (22 October 2013). <i>Proceedings of the Fourth International Congress on Hormonal Steroids: Mexico City, September 1974</i>. Elsevier Science. pp.Â 618, 620. ISBNÂ <bdi>978-1-4831-4566-2</bdi>. <q>R-2956 [41-43], a dimethyl derivative of an extremely potent androgen, R 1881 [44], is a powerful testosterone antagonist with very low androgenic activity.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Proceedings+of+the+Fourth+International+Congress+on+Hormonal+Steroids%3A+Mexico+City%2C+September+1974&amp;rft.pages=618%2C+620&amp;rft.pub=Elsevier+Science&amp;rft.date=2013-10-22&amp;rft.isbn=978-1-4831-4566-2&amp;rft.au=V.+H.+T.+James&amp;rft.au=J.+R.+Pasqualini&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DIq0aAwAAQBAJ%26pg%3DPA620&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-OstgaardWibe1981-7"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Ostgaard, K.; Wibe, E.; Eik-Nes, K. B. (1981). "Steroid responsiveness of the human cell line NHIK 3025". <i>European Journal of Endocrinology</i>. <b>97</b> (4): 551â€“558. doi:10.1530/acta.0.0970551. ISSNÂ 0804-4643.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Endocrinology&amp;rft.atitle=Steroid+responsiveness+of+the+human+cell+line+NHIK+3025&amp;rft.volume=97&amp;rft.issue=4&amp;rft.pages=551-558&amp;rft.date=1981&amp;rft_id=info%3Adoi%2F10.1530%2Facta.0.0970551&amp;rft.issn=0804-4643&amp;rft.aulast=Ostgaard&amp;rft.aufirst=K.&amp;rft.au=Wibe%2C+E.&amp;rft.au=Eik-Nes%2C+K.+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Harms1986-8"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">A. F. Harms (1 January 1986). <i>Innovative Approaches in Drug Research: Proceedings of the Third Noordwijkerhout Symposium on Medicinal Chemistry, Held in the Netherlands, September 3-6, 1985</i>. Elsevier. ISBNÂ <bdi>978-0-444-42606-2</bdi>. <q>At this stage, RU 2956 exerts a competitive effect about 4 times less marked than metribolone may be because the steric hindrance of the dimethyl group in position C-2 interferes with H-bond formation between the C-3 oxygen and the receptor protein, i.e., with the recognition step, and consequently, with the association rate.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Innovative+Approaches+in+Drug+Research%3A+Proceedings+of+the+Third+Noordwijkerhout+Symposium+on+Medicinal+Chemistry%2C+Held+in+the+Netherlands%2C+September+3-6%2C+1985&amp;rft.pub=Elsevier&amp;rft.date=1986-01-01&amp;rft.isbn=978-0-444-42606-2&amp;rft.au=A.+F.+Harms&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DPwhtAAAAMAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid6256064-9"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Eil C, Douglass EC, Rosenburg SM, Kano-Sueoka T (1981). "Receptor characteristics of the rat mammary carcinoma cell line 64-24". <i>Cancer Res</i>. <b>41</b> (1): 42â€“8. PMIDÂ 6256064.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res.&amp;rft.atitle=Receptor+characteristics+of+the+rat+mammary+carcinoma+cell+line+64-24&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=42-8&amp;rft.date=1981&amp;rft_id=info%3Apmid%2F6256064&amp;rft.aulast=Eil&amp;rft.aufirst=C&amp;rft.au=Douglass%2C+EC&amp;rft.au=Rosenburg%2C+SM&amp;rft.au=Kano-Sueoka%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid7421203-10"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Raynaud JP, Bouton MM, Moguilewsky M, Ojasoo T, Philibert D, Beck G, Labrie F, Mornon JP (January 1980). "Steroid hormone receptors and pharmacology". <i>Journal of Steroid Biochemistry</i>. <b>12</b>: 143â€“57. doi:10.1016/0022-4731(80)90264-2. PMIDÂ 7421203.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Steroid+Biochemistry&amp;rft.atitle=Steroid+hormone+receptors+and+pharmacology&amp;rft.volume=12&amp;rft.pages=143-57&amp;rft.date=1980-01&amp;rft_id=info%3Adoi%2F10.1016%2F0022-4731%2880%2990264-2&amp;rft_id=info%3Apmid%2F7421203&amp;rft.aulast=Raynaud&amp;rft.aufirst=JP&amp;rft.au=Bouton%2C+MM&amp;rft.au=Moguilewsky%2C+M&amp;rft.au=Ojasoo%2C+T&amp;rft.au=Philibert%2C+D&amp;rft.au=Beck%2C+G&amp;rft.au=Labrie%2C+F&amp;rft.au=Mornon%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid359134-11"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Ojasoo T, Raynaud JP (November 1978). "Unique steroid congeners for receptor studies". <i>Cancer Research</i>. <b>38</b> (11 Pt 2): 4186â€“98. PMIDÂ 359134.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Unique+steroid+congeners+for+receptor+studies&amp;rft.volume=38&amp;rft.issue=11+Pt+2&amp;rft.pages=4186-98&amp;rft.date=1978-11&amp;rft_id=info%3Apmid%2F359134&amp;rft.aulast=Ojasoo&amp;rft.aufirst=T&amp;rft.au=Raynaud%2C+JP&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcontent%2F38%2F11_Part_2%2F4186.short&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid3695484-12"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Ojasoo T, DelettrÃ© J, Mornon JP, Turpin-VanDycke C, Raynaud JP (1987). "Towards the mapping of the progesterone and androgen receptors". <i>J. Steroid Biochem</i>. <b>27</b> (1â€“3): 255â€“69. doi:10.1016/0022-4731(87)90317-7. PMIDÂ 3695484.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Steroid+Biochem.&amp;rft.atitle=Towards+the+mapping+of+the+progesterone+and+androgen+receptors&amp;rft.volume=27&amp;rft.issue=1%E2%80%933&amp;rft.pages=255-69&amp;rft.date=1987&amp;rft_id=info%3Adoi%2F10.1016%2F0022-4731%2887%2990317-7&amp;rft_id=info%3Apmid%2F3695484&amp;rft.aulast=Ojasoo&amp;rft.aufirst=T&amp;rft.au=Delettr%C3%A9%2C+J&amp;rft.au=Mornon%2C+JP&amp;rft.au=Turpin-VanDycke%2C+C&amp;rft.au=Raynaud%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-RaynaudOjasoo1979-13"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Raynaud, J.P.; Ojasoo, T.; Bouton, M.M.; Philibert, D. (1979). "Receptor Binding as a Tool in the Development of New Bioactive Steroids": 169â€“214. doi:10.1016/B978-0-12-060308-4.50010-X.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Receptor+Binding+as+a+Tool+in+the+Development+of+New+Bioactive+Steroids&amp;rft.pages=169-214&amp;rft.date=1979&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-060308-4.50010-X&amp;rft.aulast=Raynaud&amp;rft.aufirst=J.P.&amp;rft.au=Ojasoo%2C+T.&amp;rft.au=Bouton%2C+M.M.&amp;rft.au=Philibert%2C+D.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DbhAlBQAAQBAJ%26pg%3DPA169&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-KohtzFrye2012-14"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Kohtz, Amy S.; Frye, Cheryl A. (2012). "Dissociating Behavioral, Autonomic, and Neuroendocrine Effects of Androgen Steroids in Animal Models". <b>829</b>: 397â€“431. doi:10.1007/978-1-61779-458-2_26. ISSNÂ 1064-3745. <q>Administration of steroidal, blocking agents such as spironolactone, cyproterone acetate, or trimethyltrienolone, or nonsteroidal, such as flutamide, bicalutamide, blocking agents, can attain this result (169â€“171).</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dissociating+Behavioral%2C+Autonomic%2C+and+Neuroendocrine+Effects+of+Androgen+Steroids+in+Animal+Models&amp;rft.volume=829&amp;rft.pages=397-431&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-61779-458-2_26&amp;rft.issn=1064-3745&amp;rft.aulast=Kohtz&amp;rft.aufirst=Amy+S.&amp;rft.au=Frye%2C+Cheryl+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Brandes2012-15"><span class="mw-cite-backlink">^   </span> <span class="reference-text"><cite class="citation book">David Brandes (2 December 2012). <i>Male Accessory Sex Organs: Structure and Function in Mammals</i>. Elsevier. pp.Â 323â€“. ISBNÂ <bdi>978-0-323-14666-1</bdi>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Male+Accessory+Sex+Organs%3A+Structure+and+Function+in+Mammals&amp;rft.pages=323-&amp;rft.pub=Elsevier&amp;rft.date=2012-12-02&amp;rft.isbn=978-0-323-14666-1&amp;rft.au=David+Brandes&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTPfM6mwJozYC%26pg%3DPA323&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-pmid5443703-16"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation journal">Baulieu EE, Jung I (February 1970). "A prostatic cytosol receptor". <i>Biochem. Biophys. Res. Commun</i>. <b>38</b> (4): 599â€“606. doi:10.1016/0006-291X(70)90623-6. PMIDÂ 5443703.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.atitle=A+prostatic+cytosol+receptor&amp;rft.volume=38&amp;rft.issue=4&amp;rft.pages=599-606&amp;rft.date=1970-02&amp;rft_id=info%3Adoi%2F10.1016%2F0006-291X%2870%2990623-6&amp;rft_id=info%3Apmid%2F5443703&amp;rft.aulast=Baulieu&amp;rft.aufirst=EE&amp;rft.au=Jung%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-BonneRaynaud1974-17"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text">Bonne, C., &amp; Raynaud, J. (1974). Anti-androgenic Activity of R 2956 (17beta-hydroxy-2,2,17alpha-trimethyl-estra-4,9,11-trien-3-one). 2. Mechanism Of Action. <i>Journal de Pharmacologie</i>, 5(4), 521-532.</span>
</li>
<li id="cite_note-InabaInaba2013-18"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">Masumi Inaba; Yoshitaka Inaba (14 March 2013). <i>Androgenetic Alopecia: Modern Concepts of Pathogenesis and Treatment</i>. Springer Science &amp; Business Media. pp.Â 531â€“. ISBNÂ <bdi>978-4-431-67038-4</bdi>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Androgenetic+Alopecia%3A+Modern+Concepts+of+Pathogenesis+and+Treatment&amp;rft.pages=531-&amp;rft.pub=Springer+Science+%26+Business+Media&amp;rft.date=2013-03-14&amp;rft.isbn=978-4-431-67038-4&amp;rft.au=Masumi+Inaba&amp;rft.au=Yoshitaka+Inaba&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DRX7dBgAAQBAJ%26pg%3DPT531&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Publishers1999-19"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">Bentham Science Publishers (December 1999). <i>Current Medicinal Chemistry</i>. Bentham Science Publishers. pp.Â 1000â€“1111. <q>Several androstane derivatives have also demonstrated an antiandrogenic activity; 17a-methyl-B-nortestosterone 8 was prepared and tested in 1964 for antihormonal activity [43]. Within the next decade, several other androstane analogs were prepared and found to possess antiandrogenic activity [43, 44, 45, 46] including BOMT 9 "figure 2", R2956 10, SC9420 11, and oxendolone 12 "figure 3".</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Current+Medicinal+Chemistry&amp;rft.pages=1000-1111&amp;rft.pub=Bentham+Science+Publishers&amp;rft.date=1999-12&amp;rft.au=Bentham+Science+Publishers&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D2zI4_gEr80IC%26pg%3DPA1111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-HorskyPresl2012-20"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">J. Horsky; J. Presl (6 December 2012). <i>Ovarian Function and its Disorders: Diagnosis and Therapy</i>. Springer Science &amp; Business Media. pp.Â 112â€“. ISBNÂ <bdi>978-94-009-8195-9</bdi>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Ovarian+Function+and+its+Disorders%3A+Diagnosis+and+Therapy&amp;rft.pages=112-&amp;rft.pub=Springer+Science+%26+Business+Media&amp;rft.date=2012-12-06&amp;rft.isbn=978-94-009-8195-9&amp;rft.au=J.+Horsky&amp;rft.au=J.+Presl&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7IrpCAAAQBAJ%26pg%3DPA112&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Publishing2013-21"><span class="mw-cite-backlink"><b>^</b></span> <span class="reference-text"><cite class="citation book">William Andrew Publishing (22 October 2013). <i>Pharmaceutical Manufacturing Encyclopedia, 3rd Edition</i>. Elsevier. pp.Â 2935â€“. ISBNÂ <bdi>978-0-8155-1856-3</bdi>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Manufacturing+Encyclopedia%2C+3rd+Edition&amp;rft.pages=2935-&amp;rft.pub=Elsevier&amp;rft.date=2013-10-22&amp;rft.isbn=978-0-8155-1856-3&amp;rft.au=William+Andrew+Publishing&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D_J2ti4EkYpkC%26pg%3DPA2935-IA22&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATrimethyltrienolone"></span><link href="mw-data:TemplateStyles:r886058088" rel="mw-deduplicated-inline-style"/></span>
</li>
</ol></div></div>
<p><br/>
<span style="border: 3px solid blue; color:blue;font-weight: bold">10</span></p>
<div aria-labelledby="Androgen_receptor_modulators" class="navbox" role="navigation" style="padding:3px"></div>
<!-- 
NewPP limit report
Parsed by mw1255
Cached time: 20190422150717
Cache expiry: 2592000
Dynamic content: false
CPU time usage: 0.856 seconds
Real time usage: 1.055 seconds
Preprocessor visited node count: 6156/1000000
Preprocessor generated node count: 0/1500000
Postâ€expand include size: 156752/2097152 bytes
Template argument size: 6193/2097152 bytes
Highest expansion depth: 13/40
Expensive parser function count: 22/500
Unstrip recursion depth: 1/20
Unstrip postâ€expand size: 70071/5000000 bytes
Number of Wikibase entities loaded: 3/400
Lua time usage: 0.377/10.000 seconds
Lua memory usage: 5.44 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  823.704      1 -total
 43.53%  358.555      1 Template:Drugbox
 37.94%  312.521      1 Template:Reflist
 31.30%  257.839      1 Template:Infobox
 25.85%  212.946     11 Template:Cite_journal
  9.55%   78.665     17 Template:Unbulleted_list
  7.37%   60.668      9 Template:Cite_book
  5.99%   49.375      1 Template:Infobox_drug/chemical_formula
  5.39%   44.399      1 Template:Relative_affinities_of_antiandrogens_at_steroid-hormone_receptors
  4.93%   40.573     30 Template:Abbr
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:51309714-0!canonical and timestamp 20190422150716 and revision id 890306360
 -->
</div><noscript><img alt="" height="1" src="https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https://en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" srcset style="border: none; position: absolute;" title="" width="1"/></noscript></div>
<div class="printfooter">Retrieved from "https://en.wikipedia.org/w/index.php?title=Trimethyltrienolone&amp;oldid=890306360"</div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks">Categories: <ul><li>Drugs not assigned an ATC code</li><li>Abandoned drugs</li><li>Alcohols</li><li>Estranes</li><li>Hepatotoxins</li><li>Ketones</li><li>Steroidal antiandrogens</li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li>CS1 French-language sources (fr)</li><li>Articles without EBI source</li><li>Chemical pages without DrugBank identifier</li><li>Articles without KEGG source</li><li>Articles without UNII source</li><li>Drugs with no legal status</li><li>Articles containing unverified chemical infoboxes</li></ul></div></div>
<div class="visualClear"></div>
</div>
</div>

<div id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last edited on 31 March 2019, at 15:04<span class="anonymous-show">Â (UTC)</span>.</li>
<li id="footer-info-copyright">Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. WikipediaÂ® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy">Privacy policy</li>
<li id="footer-places-about">About Wikipedia</li>
<li id="footer-places-disclaimer">Disclaimers</li>
<li id="footer-places-contact">Contact Wikipedia</li>
<li id="footer-places-developers">Developers</li>
<li id="footer-places-cookiestatement">Cookie statement</li>
<li id="footer-places-mobileview">Mobile view</li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico">
<img alt="Wikimedia Foundation" height="31" src="https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:/static/images/wikimedia-button.png" srcset width="88"/> </li>
<li id="footer-poweredbyico">
<img alt="Powered by MediaWiki" height="31" src="https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:https:/static/images/poweredby_mediawiki_88x31.png" srcset width="88"/> </li>
</ul>
<div style="clear: both;"></div>
</div>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.856","walltime":"1.055","ppvisitednodes":{"value":6156,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":156752,"limit":2097152},"templateargumentsize":{"value":6193,"limit":2097152},"expansiondepth":{"value":13,"limit":40},"expensivefunctioncount":{"value":22,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":70071,"limit":5000000},"entityaccesscount":{"value":3,"limit":400},"timingprofile":["100.00%  823.704      1 -total"," 43.53%  358.555      1 Template:Drugbox"," 37.94%  312.521      1 Template:Reflist"," 31.30%  257.839      1 Template:Infobox"," 25.85%  212.946     11 Template:Cite_journal","  9.55%   78.665     17 Template:Unbulleted_list","  7.37%   60.668      9 Template:Cite_book","  5.99%   49.375      1 Template:Infobox_drug/chemical_formula","  5.39%   44.399      1 Template:Relative_affinities_of_antiandrogens_at_steroid-hormone_receptors","  4.93%   40.573     30 Template:Abbr"]},"scribunto":{"limitreport-timeusage":{"value":"0.377","limit":"10.000"},"limitreport-memusage":{"value":5703102,"limit":52428800}},"cachereport":{"origin":"mw1255","timestamp":"20190422150717","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Trimethyltrienolone","url":"https:\/\/en.wikipedia.org\/wiki\/Trimethyltrienolone","sameAs":"http:\/\/www.wikidata.org\/entity\/Q28209097","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q28209097","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2016-08-12T15:25:21Z","dateModified":"2019-03-31T15:04:10Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/9\/9d\/R-2956.svg"}</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":113,"wgHostname":"mw1321"});});</script>
</body>
</html>
<script>function offsetAnchor() {if(location.hash.length !== 0) {window.scrollTo(window.scrollX, window.scrollY - 250);}}window.addEventListener("hashchange", offsetAnchor);window.setTimeout(offsetAnchor, 1);</script>